CollPlant Biotechnologies Ltd.
  • About
    • About Us
    • Management Team
    • Board of Directors
    • Advisory Board
    • Partnering
  • Technology
    • rhCollagen
    • 3D Bioprinting
    • BioInk
  • Product Pipeline
    • BioInks
    • Medical Aesthetics
      • Dermal Fillers
      • Breast Implants
    • Vergenix products
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Media Room
    • Publications
    • Posters and Presentations
    • Media Coverage
    • Videos
  • Contact
    • Contact us
    • Careers
search

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • Events
    • Email Alerts
  • Company Info
    • Overview
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • Events
  • Email Alerts
Apr 25, 2022 7:00am EDT

CollPlant CEO Yehiel Tal to Moderate ISBF's virtual event on Biofabrication of Microphysiological Systems for Drug Discovery and Screening

Apr 13, 2022 7:00am EDT

CollPlant To Present at the Aesthetics Innovation Summit 2022

Mar 24, 2022 7:00am EDT

CollPlant Biotechnologies Provides Business Updates and Fiscal Year 2021 Financial Results

Feb 16, 2022 8:00am EST

CELLINK and CollPlant Enter a Collaboration Agreement to Explore Future Large-Scale Production of CollPlant's Regenerative Breast Implants using CELLINK's Bioprinting technologies

Jan 05, 2022 7:00am EST

CollPlant Issues Letter to Shareholders

Dec 02, 2021 7:00am EST

CollPlant Announces Publication Highlighting its rhCollagen-based Photocurable Dermal Filler in the Plastic and Reconstructive Surgery Journal

Nov 18, 2021 7:00am EST

CollPlant Biotechnologies Provides Business Updates and Third Quarter 2021 Financial Results

Nov 15, 2021 7:00am EST

CollPlant Announces Commercial Launch of BioInk Platform with Collink.3D™ for Use in 3D Bioprinting of Human Tissues, Scaffolds and Organs

Oct 14, 2021 7:00am EDT

CollPlant to Present at Dawson James Small Cap Growth Conference on October 21st

Oct 11, 2021 7:00am EDT

CollPlant's rhCollagen BioInk Used by Technion Researchers to Develop 3D Bioprinted Vascularized Tissue Constructs

RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...13
Next
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed

Details

exploreCollPlant Ltd

4 Oppenheimer Street
P.O. Box 4132
Rehovot 7670104, Israel

LinkedinLinkedIn YoutubeYoutube TwitterTwitter
local_phone+972 73 2325600
local_printshop+972 73 2325602
mailinfo@collplant.com

 
 

® 2022 CollPlant Biotechnologies Ltd. All rights reserved. Version: CPW 02-20